T

TILT Holdings Inc
NEO:TILT

Watchlist Manager
TILT Holdings Inc
NEO:TILT
Watchlist
Price: 0.01 CAD
Market Cap: CA$3.5m

Relative Value

There is not enough data to reliably calculate the relative value of TILT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TILT Relative Value
Base Case
Not Available
T
Worst Case
Base Case
Best Case

Multiples Across Competitors

TILT Competitors Multiples
TILT Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
TILT Holdings Inc
NEO:TILT
3.5m CAD 0 -0 -2 -0.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.4 36.5 39.1
US
Johnson & Johnson
NYSE:JNJ
538.2B USD 5.7 20 14 17.1
CH
Roche Holding AG
SIX:ROG
279.1B CHF 4.5 29.5 12.5 14.6
UK
AstraZeneca PLC
LSE:AZN
214.8B GBP 5 31 20.1 29.4
CH
Novartis AG
SIX:NOVN
223.2B CHF 5.1 19.7 15.8 20.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.5 16.8 11.7 13.6
US
Merck & Co Inc
NYSE:MRK
267.5B USD 4.2 14.1 10 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
US
Pfizer Inc
NYSE:PFE
149.5B USD 2.4 15.2 7.7 10.5
FR
Sanofi SA
PAR:SAN
97.4B EUR 1.5 7.1 6.4 6.4
P/E Multiple
Earnings Growth PEG
CA
T
TILT Holdings Inc
NEO:TILT
Average P/E: 23.1
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.4
54%
1
US
Johnson & Johnson
NYSE:JNJ
20
6%
3.3
CH
Roche Holding AG
SIX:ROG
29.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
38%
0.8
CH
Novartis AG
SIX:NOVN
19.7
17%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
16.8
2%
8.4
US
Merck & Co Inc
NYSE:MRK
14.1
14%
1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.2
27%
0.6
FR
Sanofi SA
PAR:SAN
7.1
25%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
T
TILT Holdings Inc
NEO:TILT
Average EV/EBITDA: 48
Negative Multiple: -2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.5
34%
1.1
US
Johnson & Johnson
NYSE:JNJ
14
2%
7
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
20.1
10%
2
CH
Novartis AG
SIX:NOVN
15.8
6%
2.6
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
1%
11.7
US
Merck & Co Inc
NYSE:MRK
10
6%
1.7
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.7
0%
N/A
FR
Sanofi SA
PAR:SAN
6.4
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
T
TILT Holdings Inc
NEO:TILT
Average EV/EBIT: 102.8
Negative Multiple: -0.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
37%
1.1
US
Johnson & Johnson
NYSE:JNJ
17.1
6%
2.9
CH
Roche Holding AG
SIX:ROG
14.6
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
29.4
23%
1.3
CH
Novartis AG
SIX:NOVN
20.4
12%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
13.6
0%
N/A
US
Merck & Co Inc
NYSE:MRK
11.9
8%
1.5
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.5
7%
1.5
FR
Sanofi SA
PAR:SAN
6.4
15%
0.4